Peptinil Syrup

Description

Indications

Peptinil Syrup is primarily indicated in conditions like Benign gastric and duodenal ulceration, Benign gastric ulcer, Chronic episodic dyspepsia, Duodenal ulcer, Duodenal ulceration, Duodenal ulceration associated with H. Pylori, Gastric acid reduction (surgical procedures), Gastric acidity, Gastro-oesophageal reflux disease, Heart burn, Long-term treatment of healed gastro-oesophageal reflux disease, NSAID-associated ulceration, Peptic ulcer, Post-operative ulcer, Prophylaxis of acid aspiration in obstetric patients, Prophylaxis of NSAID-associated gastric or duodenal ulcer, Prophylaxis of NSAID-induced duodenal ulcer, Prophylaxis of NSAID-induced ulcer, Prophylaxis of recurrent haemorrhage, Prophylaxis of stress ulceration, Reflux oesophagitis, Zollinger-ellison syndrome, and can also be given in adjunctive therapy as an alternative drug of choice in Helicobacter pylori infection, Long-term treatment of healed reflux oesophagitis, Longterm treatment of reflux oesophagitis, Moderate to severe reflux oesophagitis, Prophylaxis of acid aspiration in obstetrics, Prophylaxis of mendelson’s syndrome, Surgical procedures.

 Contraindication

Peptinil Syrup is contraindicated in conditions like Hypersensitivity,Pregnancy,Porphyria,Breast feeding,Pain and inflammation (rheumatic disease)

Side Effects

The severe or irreversible adverse effects of Peptinil Syrup , which give rise to further complications include Thrombocytopenia, Hepatitis, Hepatomegaly, Stevens johnson syndrome, Bradycardia, AV-block, Leucopenia, Acute pancreatitis, Pancytopenia, Marrow hypoplasia. The symptomatic adverse reactions produced by Peptinil Syrup are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Tiredness, Headache, Nausea, Diarrhea, Fever, Constipation, Rashes, Confusion, Erythema, Dysuria, Hallucination, Impotence, Darkening of stool and tongue, Depression, Arthralgia, Gynecomastia, Agitation, Anaphylactic shock.

Warnings

Peptinil Syrup should be used with caution in patients with impaired kidney or liver function. Intravenous injection should be given slowly and intravenous infusion is recommended in patients with cardiovascular impairment. Exclude the possibility of malignancy in gastric ulcer before instituting therapy. Regular supervision of patient with peptic ulcer and on non-steroidal anti-inflammatory drugs is recommended, especially if eldery.Should be avoided in the patient with history of acute porphyria.Peptinil Syrup Bismuth Citrate should be used with caution in hepatic impairment, in renal impairment, pregnancy, breast feeding.H2 receptor antagonists might mask the symptoms of gastric cancer; perticular care is required in those whose symptoms change and in those who are middle-aged or over.